Paul T. Quinlan, General Counsel at CymaBay Therapeutics, Inc. (CBAY), sold 10,000 shares at $23.58 ($236K) on 2024-01-16, disclosed to the SEC on 2024-01-16.
Open-market sale of $236k CBAY by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.58 | 5,000 | $118K | 50.0% |
| 2 | $23.58 | 5,000 | $118K | 50.0% |
| Total | $23.58 avg | 10,000 | $236K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-14 | $5.6M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $51K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $30K | — | Filing → |